Oral, Oropharyngeal & Salivary Gland Cancers | National Institute of Dental and Craniofacial Research

Skip to main content

Oral, Oropharyngeal & Salivary Gland Cancers

Notice to Extend Expiration Date for PAR-21-084 "NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)"

NOT-DE-24-019

Facing Cancer Head-On

Did You Know?

April is Oral Cancer Awareness Month. NIDCR offers resources for the general public to raise awareness of oral cancer:

Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)

PAR-24-206

Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)

PAR-24-145

Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)

PAR-24-144

Notice of Special Interest (NOSI): Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional)

NOT-OD-24-031

NIDCR Notice of Participation in PAR-24-076 "Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)"

NOT-DE-24-010

NIDCR Notice of Participation in PAR-24-075 "Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)"

NOT-DE-24-009

NIDCR is PRIMED to move AHEAD with IMPACT: Institute Awards $14 Million to Tackle Unsolved Clinical Challenges

A photo of the physician chatting with her staff while treating a patient

NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed)

RFA-DE-24-006